Anti-GPC3 Innovations Transforming Liver Cancer Care

Ajouter une nouvelle offre d'emploi Health

2025-11-12 07:40:14

The Anti-GPC3 Targeted Therapies Market is emerging as a dynamic segment within oncology, focused on precision treatments that target glypican-3 (GPC3)—a cell surface protein prominently expressed in hepatocellular carcinoma (HCC) and several solid tumors. As global liver cancer rates continue to grow, particularly in regions with high hepatitis B and C prevalence, GPC3-based therapies...

0 Commentaires 0 Parts 68 Vue 0 Aperçu